Modulation of Magnetic Resonance Spectroscopy Levels of Glutamate and GABA by Ketamine in Treatment‐Resistant Depression
Journal of Neuroscience Research · 2026
DOI: 10.1002/jnr.70102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroscience Research, 2026. Verfasst von Stephanie Njau und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, Geffen School of Medicine at the University of California, Los Angeles, Los Angeles,…. Hauptthemen laut MEDLINE: Ketamine, Glutamic Acid, Depressive Disorder, Treatment-Resistant, gamma-Aminobutyric Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Themen: Depression
Abstract (Originalsprache)
Ketamine has emerged as a highly effective intervention for treatment‐resistant depression (TRD). Though it acts as a non‐competitive antagonist of excitatory N‐methyl‐D‐aspartate receptors (NMDAR), widely expressed in the brain, including on inhibitory γ‐aminobutyric acid (GABA)‐ergic cells, the mechanisms of its antidepressant action are less clear. To investigate the links between glutamate and GABA neurotransmission and the clinical benefits of ketamine, we used proton magnetic resonance spectroscopy ( 1 H‐MRS) to measure both glutamate and GABA levels in the dorsal anterior cingulate cortex (dACC) in 60 participants with TRD before (~within 1 week), and 24 h after a 40‐min intravenous infusion with 0.5 mg/kg of racemic ( R,S )‐ketamine. The 17‐item Hamilton Depression Rating Scale (HDRS 17 ) was used as the primary measure of clinical improvement, and a 50% or greater improvement in HDRS 17 ratings was used to define treatment responders. Ketamine increased mean dACC glutamate levels in responders only 24 h after treatment ( n = 25, p = 0.01). Further, lower glutamate levels at baseline predicted greater improvements in HDRS 17 scores at 24 h post treatment ( p < 0.0001). However, GABA levels remained stable after treatment irrespective of response status ( p = 0.90). Metabolites associated with neuronal integrity (tNAA), metabolic function (tCr), and membrane turnover (tCho), which may serve as complementary biological evidence of ketamine‐induced plasticity, also increased with treatment (all p < 0.01). Results provide evidence of sustained enhancements of neurotransmission or other glutamate‐related metabolic effects following subanesthetic ketamine in responders and a potential role of ACC glutamate levels as a biomarker of responsivity to ketamine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA.
- Department of Psychiatry and Biobehavioral Sciences, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, U…
ORCID-Profile: Artemis Zavaliangos-Petropulu
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Njau, S., Zavaliangos-Petropulu, A., Joshi, S., Brooks, J., O'Neill, J., Roger, W. P., Norris, V., Espinoza, R. T., & Narr, K. L. (2026). Modulation of Magnetic Resonance Spectroscopy Levels of Glutamate and GABA by Ketamine in Treatment‐Resistant Depression. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.70102
Vancouver
Njau S, Zavaliangos-Petropulu A, Joshi S, Brooks J, O'Neill J, Roger WP, et al. Modulation of Magnetic Resonance Spectroscopy Levels of Glutamate and GABA by Ketamine in Treatment‐Resistant Depression. Journal of Neuroscience Research. 2026. doi:10.1002/jnr.70102
BibTeX
@article{Njau2026,
author = {Njau, Stephanie and Zavaliangos-Petropulu, Artemis and Joshi, Shantanu and Brooks, John and O'Neill, Joseph and Roger, Woods P and Norris, Viviane and Espinoza, Randall T and Narr, Katherine L},
title = {Modulation of Magnetic Resonance Spectroscopy Levels of Glutamate and GABA by Ketamine in Treatment‐Resistant Depression},
journal = {Journal of Neuroscience Research},
year = {2026},
doi = {10.1002/jnr.70102}
}
EUVIMED